Krystal Biotech, Inc.
KRYS
$143.96
-$2.34-1.60%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 10.56% | 3.23% | 1.56% | 5.13% | 3.97% |
Total Receivables | 7.92% | -1.42% | 7.65% | -5.75% | 122.17% |
Inventory | 3.67% | 12.95% | 42.66% | 52.57% | 10.35% |
Prepaid Expenses | 0.78% | 26.19% | 48.13% | 15.70% | 19.43% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 9.72% | 3.34% | 4.05% | 4.45% | 13.37% |
|
|||||
Total Current Assets | 9.72% | 3.34% | 4.05% | 4.45% | 13.37% |
Net Property, Plant & Equipment | -0.56% | -1.56% | -0.99% | -1.45% | -0.83% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -9.63% | -5.63% | 13.79% | 61.11% | -35.71% |
Total Assets | 5.95% | 1.76% | 7.48% | 7.05% | 7.54% |
|
|||||
Total Accounts Payable | 166.62% | -46.40% | -10.66% | 2.86% | 1.23% |
Total Accrued Expenses | 12.41% | 12.35% | 21.73% | 36.73% | 73.67% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 18.72% | 11.91% | -5.80% | -5.07% | -4.83% |
Total Finance Division Other Current Liabilities | -28.81% | -62.43% | 9.46% | 17.82% | 47.98% |
Total Other Current Liabilities | -28.81% | -62.43% | 9.46% | 17.82% | 47.98% |
Total Current Liabilities | 9.32% | -22.07% | 13.93% | 24.60% | 50.98% |
|
|||||
Total Current Liabilities | 9.32% | -22.07% | 13.93% | 24.60% | 50.98% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -2.84% | 37.33% | -2.26% | -2.24% | -2.15% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 42.70% | 37.63% | 86.47% | 29.42% | -- |
Total Liabilities | 8.92% | -18.01% | 13.46% | 22.48% | 45.72% |
|
|||||
Common Stock & APIC | 1.49% | 0.18% | 1.51% | 1.61% | 2.29% |
Retained Earnings | 26.45% | 19.78% | 20.11% | 10.73% | 5.79% |
Treasury Stock & Other | 196.67% | 305.26% | -112.57% | 338.49% | -112.04% |
Total Common Equity | 5.68% | 4.05% | 6.83% | 5.60% | 4.96% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 5.68% | 4.05% | 6.83% | 5.60% | 4.96% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 5.68% | 4.05% | 6.83% | 5.60% | 4.96% |
|